Unique ID issued by UMIN | UMIN000012697 |
---|---|
Receipt number | R000014835 |
Scientific Title | Patient satisfaction, efficacy and safety of combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes |
Date of disclosure of the study information | 2013/12/25 |
Last modified on | 2016/06/26 00:15:42 |
Patient satisfaction, efficacy and safety of combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes
Patient satisfaction of combination therapy with lixisenatide and basal insulin
Patient satisfaction, efficacy and safety of combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes
Patient satisfaction of combination therapy with lixisenatide and basal insulin
Japan |
Type 2 diabetes
Endocrinology and Metabolism |
Others
NO
To compare the patient satisfaction level of combination therapy with lixisenatide and basal insulin with that of multiple insulin injection therapy in patients with uncontrolled type 2 diabetes
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Diabetes Treatment Satisfaction Questionnaire(DTSQ) at 0 and 12 weeks after switching from multiple insulin injection therapy to combination therapy with lixisenatide and basal insulin
The daily profile of blood glucose, changes of HbA1c and body weight at 0 and 12 weeks after switching from multiple insulin injection therapy to combination therapy with lixisenatide and basal insulin
Incidence of hypoglycemia
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
Central registration
2
Treatment
Medicine |
Lixisenatide group:
In type 2 diabetic patients treated with multiple insulin injection therapy, discontinue rapid-acting insulin and add on lixisenatide at 20ug.
Continue basal insulin.
Multiple insulin group:
Continue multiple insulin injection therapy
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients whose HbA1c were >=6.0%, <9.0%, type 2 diabetic patients
2) Patients treated with multiple insulin injection therapy for more than 3 months
3) Patients whose total dose of daily insulin were <=30 units.
1) Patients who have history of diabetic ketoacidosis, or diabetic coma in the past 6 months
2) Patients who are pregnant or in lactation period
3) Patients with serious infectious disease, before operation, serious trauma
4) Patients who receive steroid therapy
5) Patients with severe liver dysfunction
6) Patients with type 1 diabetes
7) Patients with disorder of insulin secretion whose fasting serum C-peptide <0.5ng/ml
8) Patients with hypersensitivity to these medicines
9) Patients who have history of pancreas disease
10) Patients who have history of cancer
11) Patients receiving with GLP-1 receptor agonist or he DPP-4 inhibitor in the past 3 months
34
1st name | |
Middle name | |
Last name | Hideaki Miyoshi |
Hokkaido University Hospital
Department of Internal Medicine II
North 15,West 7,Kita-ku,Sapporo,Hokkaido,060-8638
011-706-5915
hmiyoshi@med.hokudai.ac.jp
1st name | |
Middle name | |
Last name | Akinobu Nakamura |
Hokkaido University Hospital
Department of Internal Medicine II
North 15,West 7,Kita-ku,Sapporo,Hokkaido,060-8638
011-706-5915
akinbo@tim.hi-ho.ne.jp
Hokkaido University Hospital
Hokkaido University Hospital
Self funding
NO
北海道大学病院(北海道)
NTT東日本札幌病院(北海道)
帯広厚生病院(北海道)
釧路赤十字病院(北海道)
苫小牧市立病院(北海道)
沖医院(北海道)
栗原内科(北海道)
青木内科クリニック(北海道)
2013 | Year | 12 | Month | 25 | Day |
Unpublished
Completed
2013 | Year | 12 | Month | 06 | Day |
2013 | Year | 12 | Month | 25 | Day |
2013 | Year | 12 | Month | 25 | Day |
2016 | Year | 06 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014835